Comparative Pharmacology
Head-to-head clinical analysis: SATRIC versus VIBATIV.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SATRIC versus VIBATIV.
SATRIC vs VIBATIV
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
Lipoglycopeptide antibiotic that inhibits cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors, blocking transglycosylation and transpeptidation. Also disrupts membrane potential and increases membrane permeability.
No standard dosing information available for SATRIC.
10 mg/kg intravenously once every 24 hours, infused over 60 minutes for 7 to 14 days.
None Documented
None Documented
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Terminal elimination half-life is approximately 177 hours (7.4 days), supporting once-daily dosing.
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Primarily renal excretion as unchanged drug (approximately 93% of dose recovered in urine; <5% in feces).
Category C
Category C
Antiprotozoal, Antibiotic
Antibiotic